When should the Oncotype DX Breast Recurrence Score® test be used?
What is the difference between genetic tests (eg, BRCA1 and BRCA2) and genomic tests like the Oncotype DX® test?
What differentiates the anatomic stages of breast cancer? How does this affect my eligibility?
What does it mean for my cancer to be HR-positive or HR-negative?
What does HER2 mean?
How long will it take to get the results of the Oncotype DX® test?
Is the Oncotype DX® test covered by insurance?
of Breast Recurrence Score test patients have $0 financial responsibility*
This calculation includes patients with Medicare, Medicare Advantage, Medicaid, Managed Medicaid, and commercial insurance. Patient cost-sharing amounts, including deductibles and copays, will vary by plan and coverage type. Only your insurer can confirm if and how Breast Recurrence Score test will be covered.
of Breast Recurrence Score test patients have a financial responsibility of <$100*
This calculation includes patients with Medicare, Medicare Advantage, Medicaid, Managed Medicaid, and commercial insurance. Patients with high-deductible plans may receive a bill for most or all the cost of the Breast Recurrence Score test if they have not satisfied their deductible.
* Testing performed at an Exact Sciences clinical lab in Redwood City, CA (Genomic Health, Inc.).
† The numbers cited are based on historical patient billing data from 1/2/2021 to 12/31/2021. Rates of coverage vary by state and region. Exceptions for coverage may apply. Exact Sciences strongly encourages you to contact your insurer with questions about Oncotype DX Breast Recurrence Score test coverage.